HIV-DART and Emerging Viruses 2024 will be held on December 1-3, 2024 at the Hacienda del mar, Los Cabos, Mexico.

The meeting will consist of invited lectures, abstract-driven presentations, poster presentations, and round-table discussions. Novel antiretroviral development, vaccine development and cure strategies for HIV will be discussed. By sharing knowledge, coordinating various activities, and working through the complex issues surrounding HIV and AIDS, the workshop aims at advancing the field towards the development of improved therapeutics and ultimately, curative strategies. Emerging viruses such as zika virus, dengue virus, chikungunya virus, norovirus, and yellow fever virus will also be discussed in terms of vaccine and drug development, epidemiology and control of transmission.

Topics of interest include: 

•Advances in antiretroviral therapy, long-acting formulations and injectable drugs for HIV•

•Novel approaches to suppress and eliminate HIV reservoirs

•HIV cure strategies

•HIV in the aging population

•Novel vaccines and immunological therapies in development

•Treatment as prevention and PrEP

•HIV co-infections with HCV, HBV and/or SARS-CoV-2

•Therapeutics and vaccine development for emerging viruses such as noro, zika, dengue, chikungunya and yellow fever virus

The program will be planned and implemented in accordance with the Essentials and Standards of the ACCME. Emory University School of Medicine is accredited by the ACCME to provide continuing medical and will award AMA PRA Category 1 CreditTM to physicians who complete this program. In the development and presentation of the program, Emory University School of Medicine will adhere to all rules, regulations and guidelines of the ACCME, AMA, AAMC, FDA and OIG that govern the conduct of accredited CME activities. All scientific materials presented will be objective and show fair balance as to the range of diagnostic and therapeutic modalities.